📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
33%
📉 Score Deterioration
40%
• Score rose 26 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
🔄 Reverse Split
15%
• Only 4 months cash — financial pressure
💹 Market Data
Market Cap$4.60M
Shares Outstanding1.04M
FloatN/A
Cash$875.4K
Debt$616.9K
Short InterestN/A
🏛 Institutional Holdings
4 institutional holders · 3.8K shares
#1
Citadel Advisors Llc
1.5K shares
#2
HRT Financial LP
1.2K shares
#3
Virtu Financial LLC
1.0K shares
+ 1 more holders Sign up free to view →
📉 Short Interest
Short Interest51.1K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for PMAX
📊 PMAX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 PMAX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.